#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of Dasatinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with MAPK/SRC Pathway Mutation

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Denmark Finland France Germany +5

  • Study of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Long‑term safety study of S68587 (allogeneic CD19 CAR T‑cells with TRAC and CD52 disruption) in patients with advanced lymphoid leukemia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    France

  • A Study of Blinatumomab in Children with Relapsed or Treatment-Resistant B Cell Acute Lymphoblastic Leukemia with Remaining Disease Traces

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy The Netherlands

  • A study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Romania +1

  • A Study Testing the Safety of CD19-Targeted CAR T-Cell Therapy in Children and Young Adults with Relapsed or Refractory B-Cell Cancers

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of TdT-3 cell therapy safety in patients aged 1 year and older with relapsed or refractory acute leukemia or lymphoblastic lymphoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Norway

  • Study on the Safety and Feasibility of CART 19/22 T Cells and CART45RA-NKG2D Cells for Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on Pegaspargase for Treating Acute Lymphoblastic Leukemia in Children and Adolescents

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of CD19-CAR_Lenti, Fludarabine, and Cyclophosphamide in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia or Aggressive B-Cell Lymphomas

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy